featured
IL-22 and Systemic Corticosteroids as Initial Treatment for Acute GVHD of the Lower GI Tract
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Blood
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
A phase 2 study of Interleukin-22 and systemic corticosteroids as initial treatment for acute GVHD of the lower GI tract
Blood 2022 Nov 18;[EPub Ahead of Print], DM Ponce, AM Alousi, R Nakamura, J Slingerland, M Calafiore, KS Sandhu, JN Barker, SM Devlin, J Shia, SA Giralt, MA Perales, GF Moore, S Fatmi, C Soto, AL Gomes, P Giardina, LT Marcello, X Yan, T Tang, K Dreyer, J Chen, WL Daley, JU Peled, MRM van den Brink, A HanashFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.